SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9371)3/24/1999 9:37:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Not sure what your point is. I do agree that there were zero deaths in P I/II due to meningococcemia. The young man that died, apparently died of other causes.

The baboons did not die. Yes I think BPI does some very good things. But by now we have had 186 in the treatment arm. I hope zero died, for the sake of the ill patients. But that does not mean I think zero died nor that this is the only thing that would be good for XOMA.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News